Celldex Therapeutics
CLDX
CLDX
102 hedge funds and large institutions have $27.4M invested in Celldex Therapeutics in 2018 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 21 increasing their positions, 37 reducing their positions, and 48 closing their positions.
Holders
102
Holders Change
-29
Holders Change %
-22.14%
% of All Funds
2.34%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
19
Increased
21
Reduced
37
Closed
48
Calls
$25K
Puts
$74K
Net Calls
-$49K
Net Calls Change
-$210K
Top Buyers
| 1 |
1
Renaissance Technologies
New York
|
$2.13M |
| 2 |
2
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
$1.32M |
| 3 |
3
Goldman Sachs
New York
|
$1.01M |
| 4 |
4
Two Sigma Investments
New York
|
$681K |
| 5 |
5
Acadian Asset Management
Boston,
Massachusetts
|
$583K |
Top Sellers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
FHA
151
Flagship Harbor Advisors
Boston,
Massachusetts
| $0 | 16 | +16 | New |
|
|
ML
152
McAdam LLC
Philadelphia,
Pennsylvania
| $0 | 42 | +42 | New |
|
153
Royal Bank of Canada
Toronto,
Ontario, Canada
| $0 | 1,083 | +1,083 | New |
|